Can silver diamine fluoride (SDF) reduce the impact on young children of waiting for dental care?

ISRCTN ISRCTN42409963
DOI https://doi.org/10.1186/ISRCTN42409963
IRAS number 351045
Secondary identifying numbers CPMS 65395
Submission date
11/03/2025
Registration date
13/03/2025
Last edited
15/04/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Dental extractions under general anaesthesia (DGA) are the most common reason for NHS hospital admission for children aged 6-10 years. Due to long waiting times for DGA, many children experience pain, infection, missed school, and sleepless nights. Silver diamine fluoride (SDF) is a treatment that can stop tooth decay in children's primary teeth. This study aims to see if using SDF can help children on DGA waiting lists by reducing pain and infection.

Who can participate?
Children aged 1-8 years who are on a DGA waiting list for dental extractions due to decayed primary teeth, along with their parents, can participate in the study.

What does the study involve?
Children will have SDF applied to their decayed primary teeth while they wait for DGA. Data will be collected on how many children accept the SDF treatment and their experiences. Parents and children will complete questionnaires about pain, infection, and oral health-related quality of life. Interviews will also be conducted to gather more detailed experiences.

What are the possible benefits and risks of participating?
The possible benefits include reduced pain and infection while waiting for DGA. Risks may include potential side effects of SDF treatment, although it is generally considered safe.

Where is the study run from?
Sheffield Teaching Hospitals NHS Foundation Trust (UK)

When is the study starting and how long is it expected to run for?
March 2025 to September 2025

Who is funding the study?
Royal College of Surgeons of England (UK)

Who is the main contact?
Dr Laura Timms, l.timms@sheffield.ac.uk

Contact information

Dr Laura Timms
Public, Scientific, Principal Investigator

School of Clinical Dentistry
University of Sheffield
Sheffield
S10 2TA
United Kingdom

ORCiD logoORCID ID 0000-0002-2738-3406
Phone +44 114 2159310
Email l.timms@sheffield.ac.uk

Study information

Study designInterventional non-randomized
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Dental clinic
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleCan silver diamine fluoride reduce negative impacts for young children with dental caries awaiting treatment under general anaesthesia: a feasibility study
Study objectivesThis feasibility study aims to investigate uncertainties around recruitment, retention and methodology that would inform a larger definitive trial to establish whether SDF reduces negative impacts for young children with dental caries while awaiting DGA.
Ethics approval(s)

Approved 03/03/2025, West Midlands - Edgbaston Research Ethics Committee (2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; +44 2071048137; edgbaston.rec@hra.nhs.uk), ref: 25/WM/0014

Health condition(s) or problem(s) studiedDental caries
InterventionBaseline information will be collected including: age, sex, ethnicity, postcode in order to determine deprivation decile, and free school meal status as a proxy for social deprivation. The number of carious teeth will be recorded, as will the number of carious teeth planned for treatment under dental general anaesthesia should different (for example, some may receive restorative treatment ahead of GA), and the number of teeth suitable for SDF application. Any medical comorbidities and medications will be recorded. Oral hygiene practice will be recorded.

The application of SDF will then be completed at either this visit or a later visit, depending on participant preference and clinical time available. The proportion of children recruited who ultimately accept the SDF treatment successfully will be recorded. Feedback will be recorded about patient, parent, and dental team experiences of SDF application. A 2-item questionnaire will be given to parents and children to ask about the acceptability/treatment experience of the SDF application. If a subsequent appointment is arranged, at the participant preference, and further SDF applied, this information will be collected again.

Every month while on the waiting list, short parental questionnaires via post/text/online/telephone (according to participant preference) will ascertain whether the child has suffered from pain or infection whilst on the waiting list. PPI advice felt this was enough time to still remember an experience of pain or infection, but not too frequent as to be a burden. This will be a 5-item questionnaire. This will be collected by LT remotely via post/text/online/telephone (according to participant preference).

Within four weeks of the DGA visit, parents and children will be asked to complete an oral health-related quality of life questionnaire. This will be the PCPQ-16 for parents and CARIES-QC for children. This will either be collected in person on the date of GA, or remotely via email, post, text, or phone call at the parents’ preference close to the time of GA (within 4 weeks).

On the date of DGA, there will be an assessment of the presence of infection on GA date to allow assessment of whether this is a suitable outcome measure, and whether it is feasible to measure on the date of GA. This will be either recorded by the local research team on the day of the DGA, or by reviewing the dental records and completing this retrospectively.

At a point during the study, interviews will be undertaken via telephone/virtual platform with children and parents depending on participant preference by LT the CI. These will last around half an hour and discuss their experiences of being part of the study, and how the study processes could be improved for a full trial. The interviews will be undertaken with children and parents present. It is anticipated due to their young age some interviews with children will lack depth, and some parents may wish to do the interview alone if they do not feel it is appropriate for their child.

Simple descriptive statistics will be undertaken for quantitative data to include rates of acceptability, recruitment, and retention. An assessment will be made of the data quality provided in order to review whether outcome measures are feasible and provide quality data. Framework analysis will be carried out for interview data. The framework will be inductive and data-driven. This will be led by LT, with review and input on the analysis from ZM, PD, HDR, and NI.
Intervention typeSupplement
Primary outcome measure1. Numbers of potential participants approached, declined, accepted, recruited is measured using a screening log and recruitment log at baseline
2. Reasons for child/parent dyads declining participation is measured using a screening log at baseline
3. Proportion of child/parent dyads recruited who accept the SDF treatment successfully is measured using a case report form (CRF) at baseline and follow-up visits
4. Feedback about patient, parent, and dental team experiences of SDF application is measured using a 2-item questionnaire at baseline and follow-up visits
5. Numbers of participants retained up to DGA is measured using a CRF and withdrawal log at baseline and follow-up visits
6. Reasons for child/parent dyads withdrawing participation is measured using a CRF and withdrawal log at baseline and follow-up visits
7. Oral health-related quality of life (OHRQoL) is measured using Caries-QC and P-CPQ questionnaires at baseline and within 4 weeks of DGA visit
8. Pain or infection while on the waiting list is measured using a 5-item parental questionnaire via post/text/online/telephone every month while on the waiting list
9. Presence of infection on GA date is measured using a CRF by the local research team on the day of DGA or by reviewing dental records retrospectively
10. Teeth with clinically arrested caries is measured using a CRF at follow-up visits
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date03/03/2025
Completion date30/09/2025

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit1 Year
Upper age limit8 Years
SexBoth
Target number of participantsPlanned Sample Size: 30; UK Sample Size: 30
Key inclusion criteria1. Children, aged 1-8 years with caries in their primary dentition
2. They will have been placed on DGA waiting lists for ‘non-urgent’ (anticipated wait time over 1 month) dental extractions/treatment of carious primary teeth at one of the participating sites
3. Parents will also be included as participants and these pairings will be termed child/parent dyads
Key exclusion criteria1. Children with medical conditions which preclude SDF treatment
Date of first enrolment01/05/2025
Date of final enrolment30/09/2025

Locations

Countries of recruitment

  • England
  • United Kingdom
  • Wales

Study participating centres

Bradford District Care NHS Foundation Trust
New Mill
Victoria Road
Saltaire
Shipley
BD18 3LD
United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Northern General Hospital
Herries Road
Sheffield
S5 7AU
United Kingdom
Cardiff & Vale University Lhb
Woodland House
Maes-y-coed Road
Cardiff
CF14 4HH
United Kingdom

Sponsor information

Sheffield Teaching Hospitals NHS Foundation Trust
Hospital/treatment centre

Northern General Hospital, Herries Road
Sheffield
S5 7AU
England
United Kingdom

Phone +44 1142265941
Email dipak.patel12@nhs.net
Website http://www.sth.nhs.uk/
ROR logo "ROR" https://ror.org/018hjpz25

Funders

Funder type

Research council

Royal College of Surgeons of England
Private sector organisation / Associations and societies (private and public)
Alternative name(s)
RCS
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available due to not having consent to share the data from participants.

Editorial Notes

15/04/2025: The recruitment start date was changed from 07/04/2025 to 01/05/2025.
11/03/2025: Trial's existence confirmed by the National Institute for Health and Care Research (NIHR) (UK).